SEC Tracker
Get the app

Syndax Pharmaceuticals SNDX

Syndax Pharmaceuticals: reports quarterly results, reports an executive or board change and makes a Regulation FD disclosure

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Syndax Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Nurix Therapeutics NRIX public float $808M, May 30, 2025
  2. Niagen Bioscience NAGE public float $814M, Jun 30, 2025
  3. Cogent Biosciences COGT public float $773M, Jun 30, 2025
  4. uniQure QURE public float $765M, Jun 30, 2025
  5. Phibro Animal Health PAHC public float $764M, Dec 31, 2025